FGSRX
Price
$119.47
Change
-$5.79 (-4.62%)
Updated
Apr 3 closing price
Net Assets
16.47B
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

FGSRX vs GFACX

Header iconFGSRX vs GFACX Comparison
Open Charts FGSRX vs GFACXBanner chart's image
Franklin Growth R
Price$119.47
Change-$5.79 (-4.62%)
VolumeN/A
Net Assets16.47B
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
FGSRX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FGSRX vs. GFACX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGSRX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. FGSRX (16.5B). FGSRX (0.00) and GFACX (0.00) have matching dividends . FGSRX was incepted earlier than GFACX: FGSRX (23 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than FGSRX (1.04). GFACX is a more actively managed with annual turnover of: 25.00 vs. FGSRX (7.35). GFACX has a lower initial minimum investment than FGSRX: GFACX (250) vs FGSRX (1000). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. FGSRX (-5.41). GFACX return over 5 years is better than : 59.73 vs. FGSRX (38.73).
FGSRXGFACXFGSRX / GFACX
Total Expense Ratio1.041.3676%
Annual Report Gross Expense Ratio1.041.3676%
Fund Existence23 years24 years-
Gain YTD-4.702-5.00394%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets16.5B280B6%
Annual Yield % from dividends0.000.00-
Returns for 1 year-5.41-1.75309%
Returns for 3 years-8.010.63-1,269%
Returns for 5 years38.7359.7365%
Returns for 10 years63.2444.46142%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences